SUMMARY Prospective studies have suggested that about 108 children with congenital cytomegalovirus (CMV) infection and bilateral sensorineural hearing loss are born each year in England and Wales; this represents about 12% of all children with congenital sensorineural hearing loss. Over a nine year period 1644 children aged between 6 months and 4 years who were attending the Nuffield Hearing and Speech Centre were screened for CMV infection. The prevalence of CMV in the urine of children with sensorineural hearing loss but no immediate family history of deafness was nearly twice that (13%) found in other children with impaired hearing and those with normal hearing (7%). These findings indicate the importance of CMV as a cause of hearing loss.
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Congenital cytomegalovirus (CMV) infection is the most common congenital infection in the United
Kingdom with a prevalence of 3-4/1000 live births. 1-3 Most congenitally infected infants are asymptomatic and the infection is unrecognised, and fewer than 10% present with clinical signs at birth or in the early neonatal period. Children with clinical infection have a high risk of handicap that considerably impairs their development.f6 In a study of 34 such infants Pass et Results CMV was isolated from the urine of 156 of 1644 children (9.5%). For each year during the study period the percentage of children with CMV in the urine varied between 9 and 11. Table 1 shows that nearly twice as many children with sensorineural hearing loss but with no family history of deafness (82 of 623, 13.2%) were shedding CMV, compared with children from the other five diagnostic groups combined (74 of 1021, 7.2%) (X2=15-8 p<0-001).
The group of children with no abnormal findings had the lowest rate of excretion of CMV.
A more detailed analysis was carried out for the 451 children who were screened between January 1976 and December 31 1980 and who had sensorineural hearing loss (table 2) . Evidence suggesting congenital rubella deafness was present in 102 children (23%). In 63 (14%) the diagnosis was considered to be probable in view of the serological findings, clinical signs, and maternal history; in 39 congenital rubella was possible, but the available The 60 children in whose urine CMV was first identified between 1974 and 1981 provided a further 149 urine samples, and the 60 children who were initially negative for CMV provided a further 144 samples. Specimens were collected at irregular intervals as children only attended the centre when there was a clinical need. The figure shows the age at which the 60 children who were initially positive for CMV were first screened, and the ages at which subsequent specimens were taken.
Twenty six children were first tested and found to be shedding virus before their second birthdays and 34 between the ages of 2 and 4 years. Overall, 47 of the 60 children shed virus intermittently-in some cases for more than five years. All but one of 13 children from whom CMV was isolated only on the group.bmj.com on June 9, 2017 -Published by http://adc.bmj.com/ Downloaded from diagnostic categories was similar for the 60 control children (table 3) . Comparison between the group positive for CMV and the controls showed no differences in maternal pregnancy history, including pre-eclampsia, urinary tract infection, hypertension, hyperemesis, or mode of delivery. Rubella infection in pregnancy was, however, more common in the control group of mothers (nine cases) than in the group positive for CMV (four cases). All 13 children whose mothers had a history of rubella in pregnancy had a sensorineural hearing loss.
The reported mean birth weight of 57 children positive for CMV was 3050 g and that of 54 controls 3260 g. There was no difference between the two groups in parents' reports of perinatal problems including jaundice, infections, breathing difficulties, or whether the infant had been nursed in an incubator.
There were two children, both shedding CMV, in whom congenital CMV hearing loss was a likely diagnosis. In one, CMV was reported to have been isolated during the neonatal period, but as the infant had been jaundiced and had received an exchange blood transfusion congenital CMV could not be distinguished from acquired CMV infection. The second child had symptoms compatible with congenital CMV (splenomegaly, petechiae, and jaundice) in the neonatal period but had also received a blood transfusion. Table 3 shows the associated clinical problems in the 60 children with CMV in the urine and their controls. Most of the children in both groups had no associated problems, but neurological abnormalities were recorded more often among those excreting CMV than among the controls.
Discussion
The presence of CMV in the urine of a child with congenital sensorineural deafness does not imply that CMV is the cause of the hearing impairment. CMV is common in young infants. In one study 12% had acquired the infection by 3 months and 20% by 1 year; these children continued to shed CMV in their urine for years. 17 The diagnosis of congenital CMV infection can be made only if the virus is isolated in the first three weeks of life or if CMV IgM is found in a serum sample collected at or shortly after birth.'7 As routine screening for CMV at birth is not carried out and would not be practicable, the 90% of infants with congenital CMV infection who are asymptomatic at birth will not be diagnosed. Should they subsequently develop a hearing impairment its cause will remain unknown.
Our finding that CMV shedding was significantly higher among children with sensorineural deafness than among children with normal hearing emphasises the importance of CMV as a cause of hearing impairment. This was further supported by the higher prevalence of CMV in the urine of children with hearing impairments who had no family history of deafness than among those with a clear family history, and by the higher prevalence of CMV in the urine of children with an uncertain history of congenital rubella compared with those in whom the diagnosis was more likely.
Apart from a history of maternal rubella, there were no differences in the antenatal or perinatal histories of children with and without CMV in the urine. This was not unexpected because congenital CMV is nearly always asymptomatic in both the mother and her infant. Examination of the clinical records showed that associated abnormalities such as motor incoordination, mental retardation, and behaviour problems were more common among the children with CMV infection than among those from whom virus was not isolated. It is not possible, however, to draw conclusions from such small numbers. As destruction of the cochleolabyrinth system, either selectively or completely, may occur after subclinical congenital CMV infection,19 vestibular abnormalities may be present in cases of focal CMV hearing loss or even in children with normal hearing. Although no specific clinical picture emerged, the finding that more of the children with CMV infection had problems of motor coordination suggests that this may be so.
The more detailed analysis of the 60 children with CMV in the urine at the initial examination shows the persistence of viral shedding in children with CMV infection. More surprising was the finding that only one child from the group from whom no CMV was isolated at the first examination subsequently shed virus, and then only on one occasion. This suggests that despite regular contact with other children, acquired infection was not common.
Some degree of hearing loss is the most common irreversible sequela of congenital CMV infection.4 5 1 The probability of sensorineural hearing loss in children with symptomatic congenital infection is about 30%,5 although even higher rates have been reported.4 This symptomatic group, however, represents fewer than 10% of congenitally infected children. The more important issue is the prevalence of sensorineural deafness in the remaining 90% with asymptomatic congenital infection who, even with a much lower risk of subsequent hearing loss, will contribute substantially to the number of children with hearing impairment born each year.
Prospective studies of children with diagnosed asymptomatic congenital CMV report wide variations in the incidence of hearing impairment.7 9 i0 i2 20 Cytomegalovirus infection and hearing loss 1237
This variation in the reported risk of deafness is due to the inclusion of minor degrees of hearing loss, some of which is unilateral and temporary. When children with more severe degrees of deafness are included-for example, those who require special educational provision-the prevalence of hearing loss reported in each study remains fairly consistent. Of over 200 children with asymptomatic congenital infection enrolled in prospective studies, about 10% have this degree of hearing loss and in 6% it is bilateral. 13 There have been a few reports of progressive hearing loss in children with congenital CMV,4 21 but the likelihood of progression from mild to functionally important hearing loss seems to be small, although this is consistent with the results of histological examination in the few cases already mentioned. 15 Because of the reduction in hearing loss due to congenital rubella infection following the introduction of immunisation against rubella the role of CMV as a cause of deafness has become increasingly important.
Assuming that there are 600 000 births each year in England and Wales and, that the rate of congenital infection with CMV is three in every 1000 births, 1800 children will be born with congenital CMV infection each year. If 6% of these children have a severe, bilateral, sensorineural hearing loss as estimated from prospective studies, this would amount to 108 congenitally infected children each year. Assuming that the incidence of moderate to severe bilateral deafness is one or two in every 1000 live births22 23 congenital CMV could account for 108 (12%) of the 900 children with sensorineural deafness born annually. 
